17 results
6-K
EX-99
BLRX
Bioline Rx Ltd
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
-readiness activities. We recently completed hiring an experienced sales force, and have substantially advanced supply chain, market access and medical
6-K
EX-99
BLRX
Bioline Rx Ltd
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
affect our operations, including potentially interrupting our supply chain, clinical trial and commercialization activities. COVID-19 originated
6-K
EX-99
BLRX
Bioline Rx Ltd
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
and may materially affect our operations, including potentially interrupting our supply chain, clinical trial and commercialization activities. COVID-19
6-K
EX-99
BLRX
Bioline Rx Ltd
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
interrupting our supply chain, clinical trial and commercialization activities. COVID-19 originated in Wuhan, China, in December 2019 and was declared a pandemic
424B5
BLRX
Bioline Rx Ltd
31 Dec 20
Prospectus supplement for primary offering
4:31pm
segments of the global economy and may materially affect our operations, including potentially interrupting our supply chain, clinical trial
424B5
20oz3ezdp c9edw1
13 Nov 20
Prospectus supplement for primary offering
4:31pm
20-F/A
9ho2jojoebx71 0l
26 Mar 24
Annual report (foreign) (amended)
4:57pm
424B5
0jyw8
25 Sep 20
Prospectus supplement for primary offering
4:30pm
424B5
b0pk4dnoxd9rh
28 May 20
Prospectus supplement for primary offering
12:00pm
424B5
ihful0pxly
3 Jun 20
Prospectus supplement for primary offering
8:33am
F-3
tgxq2hrw3 34
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
mrdrl
19 Jan 21
Prospectus supplement for primary offering
5:00pm
424B5
xrsb8u93m jut8
21 Jan 21
Prospectus supplement for primary offering
4:31pm
- Prev
- 1
- Next